New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 6, 2012
08:55 EDTALLRF, ALLRF, SPNS, SPNS, ISCO, ISCO, CATS, CATS, USAT, USAT, PVCT, PVCT, TISA, TISA, LODE, LODE, OKOFF, OKOFF, LDL, LDL, CTIB, CTIB, GPL, GPL, SMP, SMP, CLIR, CLIRWall Street Analyst Forum to host a conference
23rd Annual Investor Conference is being held in Boston on September 6-7 with webcasted company presentations to begin on September 6 at 9 am; not all company presentations may be webcasted. Webcast Link
News For ALLRF;SMP;GPL;CTIB;LDL;OKOFF;LODE;TISA;PVCT;USAT;CATS;ISCO;SPNS;CLIR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
08:39 EDTGPLGreat Panther Silver updates its diamond drilling programs for 2H15
Subscribe for More Information
06:34 EDTPVCTProvectus signs LOI with Boehringer Ingelheim China to sell PV-10 in China
Provectus has signed a Letter of Intent with Boehringer Ingelheim - China - Investment. The purpose of the LOI is to lay a foundation for the two parties to collaborate in bringing PV-10, Provectus’ novel investigational drug for cancer, to market in mainland China, Hong Kong and Taiwan. Under the terms of the LOI, Boehringer will provide certain commercially reasonable support in the aspects of product registration with the China FDA, communication preparation, market intelligence and other assistance to Provectus in China. In return, Provectus will grant Boehringer the first priority to be the exclusive collaborator of Provectus in China for PV-10 in the event that PV-10 is successfully registered and approved by the CFDA. At the appropriate time, Provectus and Boehringer will enter into a definitive agreement.
06:07 EDTPVCTProvectus' liver cancer candidate shows positive preliminary results
Provectus announced data from its phase 1 study of PV-10 for chemoablation of hepatocellular carcinoma and cancer metastatic to the liver presented at the ESMO 17th World Congress on Gastrointestinal Cancer. The main conclusion was that preliminary evidence of efficacy in treatment of liver cancers with PV-10 was observed. The current phase 1 study was designed to assess safety, pharmacokinetics, and preliminary efficacy of PV-10 in subjects with non-resectable HCC or other types of cancer metastatic to the liver. The study is continuing at three study centers with two expansion cohorts to further assess safety and response in HCC and other cancers metastatic to the liver.
June 30, 2015
08:13 EDTSPNSSapiens management to meet with Roth Capital
Meetings to be held in Los Angeles on July 7 and in San Francisco on July 8 hosted by Roth Capital.
June 26, 2015
08:54 EDTSPNSSapiens price target raised to $12 from $10 at Roth Capital
Subscribe for More Information
08:33 EDTPVCTProvectus says PV-10 data shows treatment ‘possesses favorable safety’
Provectus Biopharmaceuticals announced that Dr. Vernon Sondak presented data on “Intralesional Therapy for Melanoma with PV-10” during the 5th European Post-Chicago Melanoma/Skin Cancer Meeting in Munich, Germany. Dr. Sondak spoke during “Symposium III – New Drugs and Trials I: Immunotherapy,” held June 25. His conclusions included that “among the many agents currently being evaluated for use as intralesional therapy for melanoma, PV-10 possesses favorable safety and handling properties and induces rapid ablation of injected lesions to a degree similar to or possibly better than other agents,” and “preclinical and clinical data suggest PV-10 would be a good candidate to evaluate in conjunction with available systemic immunotherapies.”
June 23, 2015
10:00 EDTSMPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Adeptus Health (ADPT) initiated with a Buy at BofA/Merrill... Angie's List (ANGI) initiated with a Hold at Topeka... Avenue Financial (AVNU) initiated with an Equal Weight at Stephens... CASI Pharmaceuticals (CASI) initiated with a Buy at H.C. Wainwright... Corindus (CVRS) initiated with a Buy at Stifel... Coupons.com (COUP) initiated with a Market Perform at William Blair... Five Below (FIVE) initiated with an Outperform at RBC Capital... Franklin Financial Network (FSB) initiated with an Equal Weight at Stephens... Galmed (GLMD) initiated with a Buy at H.C. Wainwright... Genesis Healthcare (GEN) initiated with a Neutral at Susquehanna... Groupon (GRPN) initiated with a Hold at Topeka... GrubHub (GRUB) initiated with a Buy at Topeka... Hercules Technology (HTGC) initiated with a Buy at Compass Point... Immersion (IMMR) initiated with a Buy at Craig-Hallum... Lipocine (LPCN) initiated with a Buy at Canaccord... NeoGenomics (NEO) initiated with a Buy at BTIG... Novadaq (NVDQ) initiated with a Neutral at BTIG... Perrigo (PRGO) initiated with an Outperform at BMO Capital... Signal Genetics (SGNL) initiated with a Buy at Chardan... Standard Motor Products (SMP) initiated with a Neutral at CL King... United Community Financial (UCFC) initiated with a Market Perform at Keefe Bruyette... WP Glimcher (WPG) initiated with a Neutral at Goldman... WhiteWave (WWAV) initiated with a Buy at Maxim... Yelp (YELP) initiated with a Buy at Topeka.
June 22, 2015
16:05 EDTSMPStandard Motor Products initiated with a Neutral at CL King
June 19, 2015
07:38 EDTPVCTProvectus holder Alpha cuts share repurchase pact to $10M from $30M
Subscribe for More Information
June 18, 2015
17:31 EDTPVCTProvectus proposes public offering of common stock, warrants no amount given
Maxim Group is acting as sole book-running manager for the offering.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use